Altimmune's MASH Drug Shows Durable Liver, Weight Loss Gains At 48 Weeks

Altimmune reports positive 48-week Phase 2b data for pemvidutide in MASH, showing fibrosis improvement, weight loss, and ...

Altimmune's liver disease drug shows benefits in mid-stage study

Altimmune said on Friday its experimental liver disease drug improved signs of scarring and health of the organ after 48 weeks of treatment in a mid-stage study. The company plans to start a ...

Want to stay healthy after 40? Doctors say men should consider 14 medical tests

Men face higher chronic disease rates after 40. Learn which medical tests doctors say are vital for preventing heart attacks, ...
The Manila Times

Altimmune Announces that Pemvidutide Achieved Key Measures of Success at 48 Weeks in IMPACT Phase 2b MASH Trial

Improvements observed in key non-invasive markers of fibrosis across treatment arms versus placebo, with continued reductions from 24-week timepoint ...
Stocktwits on MSN

Altimmune stock soars over 10% premarket on positive mid-stage data for liver disease treatment drug

Shares of Altimmune, Inc. (ALT) jumped 16% in premarket trading on Friday after it reported positive topline results from its ...
Orlando Magazine

2025 Finest Physicians Profile: Center for Digestive Health

Founded in 1982, the Center for Digestive Health has provided the highest level of Gastroenterology care since its inception ...
eLife

Global molecular landscape of early MASLD progression in obesity

The authors provide a useful integrated analytical approach to investigating MASLD focused on diverse multiomic integration methods. The strength of evidence for this new resource is solid, as ...
Daily Excelsior

DRDDC organises ‘Multi Speciality Free Test Camp’

Datta Ranpat Dev Dramatic Club (DRDDC) here today under the leadership of its president, Pushpinder Singh Charak organized a multi speciality free medical test camp in Channi Himmat. Dr. Rajesh Gupta, ...

CDC vaccine advisers’ new focus on hepatitis B tests in pregnancy is not enough, some doctors warn

Relying on testing to guide vaccination recalls an approach the United States tried in the 1980s and early ’90s that still led to thousands of cases of hepatitis B among children every year.
The Pioneer

Metropolis healthcare launches scientifically curated GLP-1 monitoring test packages

India’s second-largest and the most respected pathology laboratory chain, today announced the launch of three specialised metabolic health packages under its TruHealth portfolio. These have been desig ...

Wegovy(R) (semaglutide injection) Receives Conditional Marketing Authorization from Health Canada as the First and Only Treatment for Adults with Non-Cirrhotic MASH, a Serious ...

The MarketWatch News Department was not involved in the creation of this content.-- Wegovy(R) (semaglutide injection) granted conditional marketing authorization for the treatment ...
Medical Xpress

Q&A: Why it is important to increase screening and treatment of hepatitis delta virus

Hepatitis delta virus (HDV), a bloodborne infection that is transmitted through infected blood or other bodily fluids, was recently designated as a Group 1 carcinogen by the International Agency for ...